In an effort to elucidate how MRPS31 loss-mediated mitoribosomal defects modulate hepatoma cell activity, we identified COL1A1, a component of type I collagen, as a key downstream effector molecule. This evidence concerns the gene MRPS31 and hepatocellular carcinoma.